Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Al-Younes, HM; Rudel, T; Brinkmann, V; Szczepek, AJ; Meyer, TF
   Low iron availability modulates the course of Chlamydia pneumoniae infection
   CELLULAR MICROBIOLOGY
   
   H.M. Al-Younes et al., "Low iron availability modulates the course of Chlamydia pneumoniae infection", CELL MICROB, 3(6), 2001, pp. 427-437
2. Szczepek, AJ; Belch, AR; Pilarski, LM
   Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells inmultiple myeloma: Potential for autocrine and paracrine networks
   EXPERIMENTAL HEMATOLOGY
   
   A.J. Szczepek et al., "Expression of IL-6 and IL-6 receptors by circulating clonotypic B cells inmultiple myeloma: Potential for autocrine and paracrine networks", EXP HEMATOL, 29(9), 2001, pp. 1076-1081
3. Rajalingam, K; Al-Younes, H; Muller, A; Meyer, TF; Szczepek, AJ; Rudel, T
   Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis
   INFECTION AND IMMUNITY
   
   K. Rajalingam et al., "Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis", INFEC IMMUN, 69(12), 2001, pp. 7880-7888
4. Reiman, T; Seeberger, K; Taylor, BJ; Szczepek, AJ; Hanson, J; Mant, MJ; Coupland, RW; Belch, AR; Pilarski, LM
   Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone
   BLOOD
   
   T. Reiman et al., "Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone", BLOOD, 98(9), 2001, pp. 2791-2799
5. Pilarski, LM; Giannakopoulos, NV; Szczepek, AJ; Masellis, AM; Mant, MJ; Belch, AR
   In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease
   CLINICAL CANCER RESEARCH
   
   L.M. Pilarski et al., "In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease", CLIN CANC R, 6(2), 2000, pp. 585-596
6. SZCZEPEK AJ; SEEBERGER K; WIZNIAK J; MANT MJ; BELCH AR; PILARSKI LM
   A HIGH-FREQUENCY OF CIRCULATING B-CELLS SHARE CLONOTYPIC IG HEAVY-CHAIN VDJ REARRANGEMENTS WITH AUTOLOGOUS BONE-MARROW PLASMA-CELLS IN MULTIPLE-MYELOMA, AS MEASURED BY SINGLE-CELL AND IN-SITU REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION
   Blood
   
   A.J. Szczepek et al., "A HIGH-FREQUENCY OF CIRCULATING B-CELLS SHARE CLONOTYPIC IG HEAVY-CHAIN VDJ REARRANGEMENTS WITH AUTOLOGOUS BONE-MARROW PLASMA-CELLS IN MULTIPLE-MYELOMA, AS MEASURED BY SINGLE-CELL AND IN-SITU REVERSE-TRANSCRIPTASE POLYMERASE-CHAIN-REACTION", Blood, 92(8), 1998, pp. 2844-2855
7. PILARSKI LM; SZCZEPEK AJ; BELCH AR
   DEFICIENT DRUG TRANSPORTER FUNCTION OF BONE MARROW-LOCALIZED AND LEUKEMIC PLASMA-CELLS IN MULTIPLE-MYELOMA
   Blood
   
   L.M. Pilarski et al., "DEFICIENT DRUG TRANSPORTER FUNCTION OF BONE MARROW-LOCALIZED AND LEUKEMIC PLASMA-CELLS IN MULTIPLE-MYELOMA", Blood, 90(9), 1997, pp. 3751-3759
8. PILARSKI LM; SZCZEPEK AJ; MANT MJ; BELCH AR
   CRYPTIC EXPRESSION OF THE CD19 EPITOPE DETECTED BY MAB LEU12 DISTINGUISHES MALIGNANT FROM RESIDUAL POLYCLONAL B-CELLS IN THE BLOOD OF MYELOMA PATIENTS
   Blood
   
   L.M. Pilarski et al., "CRYPTIC EXPRESSION OF THE CD19 EPITOPE DETECTED BY MAB LEU12 DISTINGUISHES MALIGNANT FROM RESIDUAL POLYCLONAL B-CELLS IN THE BLOOD OF MYELOMA PATIENTS", Blood, 90(10), 1997, pp. 1557-1557
9. SZCZEPEK AJ; BELCH AR; MANT MJ; PILARSKI LM
   AUTOCRINE GROWTH-REGULATION OF CIRCULATING CLONOTYPIC B-CELLS IN HUMAN MULTIPLE-MYELOMA - INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR EXPRESSION
   Blood
   
   A.J. Szczepek et al., "AUTOCRINE GROWTH-REGULATION OF CIRCULATING CLONOTYPIC B-CELLS IN HUMAN MULTIPLE-MYELOMA - INTERLEUKIN-6 AND INTERLEUKIN-6 RECEPTOR EXPRESSION", Blood, 90(10), 1997, pp. 1566-1566
10. BELCH AR; SZCZEPEK AJ; PILARSKI LM
    DRUG-RESISTANT MALIGNANT B-CELLS IN MULTIPLE-MYELOMA EXPRESS CD11B AND CLONOTYPIC TRANSCRIPTS
    Blood
    
    A.R. Belch et al., "DRUG-RESISTANT MALIGNANT B-CELLS IN MULTIPLE-MYELOMA EXPRESS CD11B AND CLONOTYPIC TRANSCRIPTS", Blood, 90(10), 1997, pp. 2344-2344
11. SZCZEPEK AJ; BERGSAGEL PL; AXELSSON L; BROWN CB; BELCH AR; PILARSKI LM
    CD34(-MYELOMA EXPRESS CD19 AND IGH MESSENGER-RNA AND HAVE PATIENT-SPECIFIC IGH VDJ GENE REARRANGEMENTS() CELLS IN THE BLOOD OF PATIENTS WITH MULTIPLE)
    Blood
    
    A.J. Szczepek et al., "CD34(-MYELOMA EXPRESS CD19 AND IGH MESSENGER-RNA AND HAVE PATIENT-SPECIFIC IGH VDJ GENE REARRANGEMENTS() CELLS IN THE BLOOD OF PATIENTS WITH MULTIPLE)", Blood, 89(5), 1997, pp. 1824-1833
12. SZCZEPEK AJ; BELCH AR; MANT MJ; PILARSKI LM
    IN MULTIPLE-MYELOMA, 10-90-PERCENT OF BLOOD B-CELLS HAVE AN IGH CDR3 IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS, QUANTITATED USING SINGLE-CELL PCR, RT-PCR AND IN-SITU RT-PCR
    Blood
    
    A.J. Szczepek et al., "IN MULTIPLE-MYELOMA, 10-90-PERCENT OF BLOOD B-CELLS HAVE AN IGH CDR3 IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS, QUANTITATED USING SINGLE-CELL PCR, RT-PCR AND IN-SITU RT-PCR", Blood, 88(10), 1996, pp. 1553-1553
13. BELCH AR; SZCZEPEK AJ; PILARSKI LM
    CD34(-CELLS IN MULTIPLE-MYELOMA HAVE A REARRANGED IGH VDJ IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS AS QUANTITATED BY IN-SITU RT-PCR() CIRCULATING B)
    Blood
    
    A.R. Belch et al., "CD34(-CELLS IN MULTIPLE-MYELOMA HAVE A REARRANGED IGH VDJ IDENTICAL TO THAT OF AUTOLOGOUS PLASMA-CELLS AS QUANTITATED BY IN-SITU RT-PCR() CIRCULATING B)", Blood, 88(10), 1996, pp. 1554-1554
14. SZCZEPEK AJ; BELCH AR; MANT MJ; MACDONALD H; PILARSKI LM
    ABNORMAL CYTOKINE EXPRESSION PROFILE IN B-LYMPHOCYTE AND T-LYMPHOCYTEFRESHLY ISOLATED FROM PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS
    Blood
    
    A.J. Szczepek et al., "ABNORMAL CYTOKINE EXPRESSION PROFILE IN B-LYMPHOCYTE AND T-LYMPHOCYTEFRESHLY ISOLATED FROM PERIPHERAL-BLOOD OF MULTIPLE-MYELOMA PATIENTS", Blood, 86(10), 1995, pp. 241-241